46 research outputs found

    Panspermia, Past and Present: Astrophysical and Biophysical Conditions for the Dissemination of Life in Space

    Full text link
    Astronomically, there are viable mechanisms for distributing organic material throughout the Milky Way. Biologically, the destructive effects of ultraviolet light and cosmic rays means that the majority of organisms arrive broken and dead on a new world. The likelihood of conventional forms of panspermia must therefore be considered low. However, the information content of dam-aged biological molecules might serve to seed new life (necropanspermia).Comment: Accepted for publication in Space Science Review

    Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism

    Get PDF
    From the identification of HIV as the agent causing AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research over the past twenty-six years have been formidable. Currently, there are twenty-five anti-HIV compounds which have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs), nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), cell entry inhibitors or fusion inhibitors (FIs), co-receptor inhibitors (CRIs), and integrase inhibitors (INIs). Metabolism by the host organism is one of the most important determinants of the pharmacokinetic profile of a drug. Formation of active or toxic metabolites will also have an impact on the pharmacological and toxicological outcomes. Therefore, it is widely recognized that metabolism studies of a new chemical entity need to be addressed early in the drug discovery process. This paper describes an overview of the metabolism of currently available anti-HIV drugs.Da identificação do HIV como o agente causador da AIDS, ao desenvolvimento de fĂĄrmacos antirretrovirais eficazes, os avanços cientĂ­ficos na pesquisa sobre o HIV nos Ășltimos vinte e seis anos foram marcantes. Atualmente, existem vinte e cinco fĂĄrmacos anti-HIV formalmente aprovados pelo FDA para utilização clĂ­nica no tratamento da AIDS. Estes compostos sĂŁo divididos em seis classes: inibidores nucleosĂ­deos de transcriptase reversa (INTR), inibidores nucleotĂ­deos de transcriptase reversa (INtTR), inibidores nĂŁo-nucleosĂ­deos de transcriptase reversa (INNTR), inibidores de protease (IP), inibidores da entrada celular ou inibidores de fusĂŁo (IF), inibidores de co-receptores (ICR) e inibidores de integrase (INI). O metabolismo consiste em um dos maiores determinantes do perfil farmacocinĂ©tico de um fĂĄrmaco. A formação de metabĂłlitos ativos ou tĂłxicos terĂĄ impacto nas respostas farmacolĂłgicas ou toxicolĂłgicas do fĂĄrmaco. Portanto, Ă© amplamente reconhecido que estudos do metabolismo de uma nova entidade quĂ­mica devem ser realizados durante as fases iniciais do processo de desenvolvimento de fĂĄrmacos. Este artigo descreve uma abordagem do metabolismo dos fĂĄrmacos anti-HIV atualmente disponĂ­veis na terapĂȘutica

    Modifications de l’activitĂ© Ă©lectrique cĂ©rĂ©brale spontanĂ©e et Ă©voquĂ©e chez le lapin adulte soumis Ă  une irradiation Îł globale

    No full text
    L’irradiation Îł globale comprise entre 150 et 850 rads (dĂ©bit de 14 rad.min-1) entraĂźne chez le lapin adulte muni d’électrodes chroniquement implantĂ©es des modifications immĂ©diates et retardĂ©es du comportement, de la vigilance et des activitĂ©s Ă©lectriques cĂ©rĂ©brales spontanĂ©es et Ă©voquĂ©es. Les techniques electrophysiologiques d’enregistrement polygraphique et les mĂ©thodes de traitement du signal permettent d’établir que ces altĂ©rations sont reliĂ©es Ă  la dose absorbĂ©e. La dose-seuil s’accompagnant de modifications transitoires de la vigilance serait comprise entre 50 et 100 rads ; au-dessous de cette gamme de dose, l’irradiation agirait, Ă  l’exclusion d’éventuelles modifications du comportement, comme une stimulation, qui ne deviendrait nociceptive que pour des doses plus Ă©levĂ©es
    corecore